The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR

Liang Zhou(South China University of Technology), Steven Grant(Virginia Commonwealth University), Allison Berger(Takeda (United States)), Yun Leng(Capital Medical University), Mohamed Rahmani(Khalifa University of Science and Technology), Yun Dai(University of Miami), Hui‐Yi Lin(Moffitt Cancer Center), Kathryn Rizzo, Lawrence F. Povirk(Virginia Commonwealth University), Catherine I. Dumur, Maciej Kmieciak(Virginia Commonwealth University), Andrea Ferreira‐Gonzalez, Yu Zhang(Wannan Medical College), Shuang Chen(Shihezi University), Lihong Li(Capital Medical University), Sri Lakshmi Chalasani(Virginia Commonwealth University)
Blood
February 5, 2016
10.1182/blood-2015-06-653717
Cited by 58

Related Papers

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
|Nature|2009|2k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma
|Blood|2010|323
Exosomes derived from mesenchymal stem cells reverse EMT via TGF-β1/Smad pathway and promote repair of damaged endometrium
|Stem Cell Research & Therapy|2019|294
Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of Translation
|Journal of Biological Chemistry|2005|284